Search Results - "Thomas A Caputo"

Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? by Kahn, Ryan M., Gordhandas, Sushmita, Maddy, Brandon Paul, Baltich Nelson, Becky, Askin, Gulce, Christos, Paul J., Caputo, Thomas A., Chapman‐Davis, Eloise, Holcomb, Kevin, Frey, Melissa K.

“…Background Universal tumor testing for defective DNA mismatch repair (MMR) is recommended for all women diagnosed with endometrial cancer to identify those…”
Get full text

Disparities in Gynecological Malignancies by Chatterjee, Sudeshna, Gupta, Divya, Caputo, Thomas A, Holcomb, Kevin

“…Health disparities and inequalities in access to care among different socioeconomic, ethnic, and racial groups have been well documented in the U.S. healthcare…”
Get full text

Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study by Minis, Evelyn, Holcomb, Kevin, Sisti, Giovanni, Nasioudis, Dimitrios, Kanninen, Tomi T, Athanasiou, Aikaterini, Frey, Melissa K, Chapman-Davis, Eloise, Caputo, Thomas A, Witkin, Steven S

“…There remains a need to differentiate between women with a benign or a malignant adnexal mass prior to surgery. As part of an ongoing evaluation of vaginal…”
Get full text

Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma by Kudesia, Rashmi, MD, Singer, Tomer, MD, Caputo, Thomas A., MD, Holcomb, Kevin Michael, MD, Kligman, Isaac, MD, Rosenwaks, Zev, MD, Gupta, Divya, MD

“…Objectives This study evaluated fertility and oncological outcomes in women with complex atypical hyperplasia (CAH) or nonmyoinvasive grade 1 endometrioid…”
Get full text

Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes by Manzerova, Julia, Sison, Cristina P, Gupta, Divya, Holcomb, Kevin, Caputo, Thomas A, Parashar, Bhupesh, Nori, Dattatreyudu, Wernicke, A. Gabriella

“…Abstract Objective To examine clinical and demographic characteristics of a population-based cohort of patients with uterine carcinosarcoma (UCS), to assess…”
Get full text

Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors by Nasioudis, Dimitrios, Orfanelli, Theofano, Frey, Melissa K, Chapman-Davis, Eloise, Caputo, Thomas A, Witkin, Steven S, Holcomb, Kevin

“…To investigate the role of adjuvant chemotherapy (CT) in the management of ovarian non-granulosa cell (GC) sex cord-stromal tumors (SCSTs). The National Cancer…”
Get full text

Intravenous leiomyomatosis with intracardiac extension: a single-institution experience by Worley, Micheal J., MD, Aelion, Anate, MD, Caputo, Thomas A., MD, Kent, Kenneth C., MD, Salemi, Arash, MD, Krieger, Karl H., MD, Goldstein, Michael J., MD, Kuo, Dennis Y., MD, Slomovitz, Brian M., MD

“…Objective The aim of this study was to outline the surgical management and outcomes for patients diagnosed with intravenous leiomyomatosis with intracardiac…”
Get full text

Physician knowledge of and adherence to the revised breast cancer screening guidelines by the United States Preventive Services Task Force by Hinz, Erica K., BSE, Kudesia, Rashmi, MD, Rolston, Renee, BS, Caputo, Thomas A., MD, Worley, Michael J., MD

“…Objective We sought to assess knowledge and adherence to the revised US Preventive Services Task Force breast cancer screening guidelines among gynecologic…”
Get full text

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling by Frey, Melissa K, Kahn, Ryan M, Chapman-Davis, Eloise, Tubito, Francesca, Pires, Maira, Christos, Paul, Anderson, Samantha, Mukherjee, Semanti, Jordan, Bailey, Blank, Stephanie V, Caputo, Thomas A, Sharaf, Ravi N, Offit, Kenneth, Holcomb, Kevin, Lipkin, Steven

“…Probands with newly diagnosed cancer-associated pathogenic variants were offered facilitated cascade testing whereby the genetics team identified and contacted…”
Get full text

Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base by Nasioudis, Dimitrios, Chapman-Davis, Eloise, Frey, Melissa K., Caputo, Thomas A., Holcomb, Kevin

“…•Administration of adjuvant chemotherapy results is better survival for OYSTs.•Age and disease stage are independently associated with…”
Get full text

Pelvic splenosis misdiagnosed as a uterine sarcoma by Gerber, Deanna, Frey, Melissa K, Caputo, Thomas A

“…Highlights • Splenosis is a rare complication of splenic trauma or splenectomy. • Splenosis can be mistaken for gynecologic malignancy. • Splenosis must be…”
Get full text

Fertility-preserving surgery for advanced stage ovarian germ cell tumors by Nasioudis, Dimitrios, Frey, Melissa K., Chapman-Davis, Eloise, Caputo, Thomas A., Holcomb, Kevin

“…To evaluate the prevalence and safety of uterine preservation among premenopausal women diagnosed with a malignant ovarian germ-cell tumor (MOGCT) of advanced…”
Get full text

Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors by Dimitrios Nasioudis, Theofano Orfanelli, Melissa K Frey, Eloise Chapman-davis, Thomas A Caputo, Steven S Witkin, Kevin Holcomb

“…Objective: To investigate the role of adjuvant chemotherapy (CT) in the management of ovarian non-granulosa cell (GC) sex cord-stromal tumors (SCSTs). Methods:…”
Get full text

Low-grade serous ovarian cancer: State of the science by Slomovitz, Brian, Gourley, Charlie, Carey, Mark S., Malpica, Anais, Shih, Ie-Ming, Huntsman, David, Fader, Amanda N., Grisham, Rachel N., Schlumbrecht, Matthew, Sun, Charlotte C., Ludemann, Jane, Cooney, Gail Austin, Coleman, Robert, Sood, Anil K., Mahdi, Haider, Wong, Kwong K., Covens, Allan, O'Malley, David M., Lecuru, Fabrice, Cobb, Lauren P., Caputo, Thomas A., May, Taymaa, Huang, Marilyn, Siemon, John, Fernández, Marta Llauradó, Ray-Coquard, Isabelle, Gershenson, David M.

“…In January 2019, a group of basic, translational, and clinical investigators and patient advocates assembled in Miami, Florida, to discuss the current state of…”
Get full text

Primary malignant ovarian carcinoid; management and outcomes by Nasioudis, Dimitrios, Frey, Melissa K., Chapman-Davis, Eloise, Caputo, Thomas A., Holcomb, Kevin

“…To investigate the clinicopathological characteristics and survival of patients with malignant ovarian carcinoid tumor (OC). The National Cancer Database was…”
Get full text

A case report of hereditary leiomyomatosis and renal cell cancer by Frey, Melissa K., MD, Worley, Michael J., MD, Heyman, Katherine P., BA, Caputo, Thomas A., MD

“…A 27-year-old woman, gravida 0, presented with uterine and cutaneous leiomyomata. Genetic testing confirmed hereditary leiomyomatosis and renal cell cancer…”
Get full text

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study by Kuo, Dennis Yi-Shin, Blank, Stephanie V, Christos, Paul J, Kim, Mimi, Caputo, Thomas A, Pothuri, Bhavana, Hershman, Dawn, Goldman, Noah, Ivy, Percy S, Runowicz, Carolyn D, Muggia, Franco, Goldberg, Gary L, Einstein, Mark H

“…Abstract Objective Survival in women with recurrent or metastatic cervical cancer remains poor. More effective and less toxic regimens are needed. Cisplatin is…”
Get full text

Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB? by Nasioudis, Dimitrios, Chapman-Davis, Eloise, Frey, Melissa K., Caputo, Thomas A., Witkin, Steven S., Holcomb, Kevin

“…According to the revised FIGO staging system women with ovarian carcinoma and inguinal lymph node (LN) metastases, formerly stage III, are now considered stage…”
Get full text

Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix by Nasioudis, Dimitrios, Frey, Melissa K, Chapman-Davis, Eloise, Caputo, Thomas A, Holcomb, Kevin

“…Most studies evaluating the oncologic safety of minimally invasive surgery for endometrial cancer focus on patients with stage I disease. The aim of this study…”
Get more information

Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database by Nasioudis, Dimitrios, Frey, Melissa K., Chapman-Davis, Eloise, Caputo, Thomas A., Holcomb, Kevin M.

“…Investigate the use and outcomes of a surveillance only strategy for patients with high-risk stage I malignant ovarian germ cell tumors. Patients with…”
Get full text